- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Pulmonary Atelectasis in South Africa
Total 800 results
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Germany, Ukraine, United States, Estonia, South Africa, Sweden, Norway, Russian Federation, Korea, Republic of
-
Soroka University Medical CenterRecruitingLung Diseases, Obstructive | Pulmonary Disease, Chronic Obstructive | Asthma | COPDIsrael
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseUnited States, New Zealand, Belgium
-
AstraZenecaAmgenCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Canada, Denmark, France, United Kingdom, Korea, Republic of, Germany, Israel, Spain, Netherlands
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseKorea, Republic of, Austria, Belgium, Germany, Greece, Russian Federation, Australia, Brazil, Canada, Denmark, France, Hungary, Israel, Italy, Netherlands, Poland, Slovakia, South Africa, Spain, Turkey, United Kingdom
-
Gilead SciencesTerminatedIdiopathic Pulmonary Fibrosis | Pulmonary HypertensionUnited States, Germany, United Kingdom, Australia, Canada, Italy, Austria
-
University of North Carolina, Chapel HillEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedPersistent Pulmonary Hypertension of the NewbornUnited States
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Czech Republic, Poland, South Africa, Netherlands
-
AstraZenecaParexel International Ltd; Cognizant Technology Solution; Center for Information... and other collaboratorsCompletedChronic Obstructive Pulmonary Disease COPDUnited States, Canada, France, Russian Federation, Ukraine, Hungary, Bulgaria
-
Medical University of South CarolinaCompletedPulmonary Disease, Chronic Obstructive | Telemedicine | Cigarette SmokingUnited States
-
United TherapeuticsTerminatedChronic Obstructive Pulmonary Disease | Pulmonary HypertensionUnited States, Israel, Argentina, Puerto Rico
-
Hoffmann-La RocheRecruitingChronic Obstructive Pulmonary DiseaseUnited States, Belgium, Australia, Israel, Spain, France, United Kingdom, Denmark, Argentina, Germany, New Zealand, South Africa, Korea, Republic of, Poland, Bulgaria, Canada, Chile, Czechia, Netherlands, Romania, Sweden, Mexico
-
AstraZenecaMedImmune LLCCompletedModerate to Very Severe Chronic Obstructive Pulmonary DiseaseUnited States, Canada, Germany, Italy, Netherlands, Spain, United Kingdom, Poland, Japan, Austria, Korea, Republic of, Russian Federation, South Africa, Czechia, Hungary, Romania, Switzerland
-
Boehringer IngelheimCompleted
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Colombia, Spain, Canada, Slovakia, India, Netherlands, Czech Republic, Hungary
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Canada
-
United TherapeuticsActive, not recruitingPulmonary Arterial HypertensionUnited States
-
MedImmune LLCCompletedChronic Obstructive Pulmonary DiseaseUnited States, Bulgaria, Czech Republic, Poland, United Kingdom, Philippines, Latvia, Lithuania, Ukraine, Hungary
-
Janssen Research & Development, LLCCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom, United States, Belgium, Germany, Romania, Canada, Netherlands, Russian Federation, Poland, Hungary, Czechia
-
Global Alliance for TB Drug DevelopmentCompletedTuberculosis | Tuberculosis, Pulmonary | Tuberculosis, Multidrug-Resistant | Tuberculosis, MDR | Drug-Resistant TuberculosisTanzania, Georgia, Russian Federation, Brazil, Malaysia, Philippines, South Africa, Uganda
-
United TherapeuticsTerminatedPulmonary Hypertension Associated With HFpEFUnited States
-
Molecure S.A.RecruitingPulmonary SarcoidosisUnited States, United Kingdom
-
Pulmonary Hypertension Association, Inc.University of Washington, the Collaborative Health Studies Coordinating CenterRecruitingPulmonary Arterial Hypertension | Pulmonary Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited States
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Gilead SciencesCompletedPulmonary HypertensionUnited States, Australia, Argentina, Canada, Mexico, Brazil, Chile, Russian Federation, Ukraine
-
Gilead SciencesCompletedPulmonary HypertensionUnited States, Canada, Australia
-
SanofiRegeneron PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUkraine, Argentina, Chile, Poland, Russian Federation, Turkey, United States, Australia, Canada, Germany
-
Hoffmann-La RocheCompletedChronic Obstructive Pulmonary DiseaseUnited States, Canada, Bulgaria, Hungary, Russian Federation, Denmark, Argentina, Mexico, Poland
-
Centers for Disease Control and PreventionTuberculosis Trials ConsortiumRecruitingTuberculosis, Pulmonary | Tuberculosis InfectionCanada, United States, Haiti, South Africa, Uganda, Vietnam
-
United TherapeuticsWithdrawnPulmonary HypertensionUnited States, Australia, Mexico
-
Aerovate TherapeuticsRecruitingPulmonary Arterial HypertensionUnited States, Belgium, Italy, Spain, Australia, Canada, China, Poland, Singapore, Argentina, United Kingdom, France, Israel, Latvia, Austria, Mexico, Puerto Rico, Sweden, South Africa, Netherlands, Chile, Germany, Greece, Portugal, Cze... and more
-
AmgenActive, not recruitingIdiopathic Pulmonary FibrosisUnited States, Spain, Korea, Republic of, Australia, Japan, Canada, Taiwan, Netherlands, Italy, Chile, Greece, Mexico, Germany, France, Argentina, Poland, Turkey, South Africa, United Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, France, Romania, Finland, Taiwan, Bulgaria, Estonia, Canada, Netherlands, Philippines, South Africa, Sweden, Spain, Singapore, Austria, Germany, Latvia, New Zealand, China, Ukraine, Thailand, Greece, United Kingdom and more
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedPulmonary Arterial Hypertension, ChildrenUnited States, Taiwan, Guatemala, Russian Federation, Japan, Chile, Colombia, Canada, Italy, Hungary, Poland, Peru, Sweden, Brazil, India, Malaysia, Mexico
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Germany, Estonia, Ukraine, Korea, Republic of, Norway, Czechia
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
United TherapeuticsCompletedPulmonary HypertensionUnited States, United Kingdom, Canada, Spain, Australia, Israel, Germany, Belgium, France, Austria, Italy, Poland, Ireland, Netherlands
-
Duke UniversityBoehringer IngelheimRecruitingIdiopathic Pulmonary Fibrosis, Interstitial Lung DiseaseUnited States, Puerto Rico
-
SanofiCompletedIdiopathic Pulmonary FibrosisSpain, United States, Canada, Chile, Mexico
-
Eiger BioPharmaceuticalsTerminatedPulmonary Arterial HypertensionUnited States, Canada
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
NovartisCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseGermany, United States, Colombia, Poland, South Africa, Canada, Estonia, Hungary, India, Austria, Israel, Netherlands, United Kingdom, Argentina, France, Italy, Spain, Czech Republic, Denmark, Finland, Greece, Ireland, Mexico, Peru, Phi... and more
-
Guy's and St Thomas' NHS Foundation TrustKing's College London; University of Nottingham; Imperial College London; University... and other collaboratorsNot yet recruitingCOPD | COPD ExacerbationUnited Kingdom
-
BellerophonActive, not recruitingPulmonary Fibrosis | Pulmonary HypertensionUnited States
-
Sunovion Respiratory Development Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States, Czechia, Hungary, Russian Federation
-
Olympus Corporation of the AmericasRecruiting
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States